Read More 6 minute read Pharma Industry News Natera boosts ctDNA and lymphoma detection capabilities through Foresight Diagnostics acquisition Find out how Natera’s acquisition of Foresight Diagnostics could redefine ultra-sensitive cancer detection and reshape the future of MRD testing. bySoujanya RaviDecember 5, 2025